Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Sci ; 42(4): 313-7, 2011 Mar 18.
Article in English | MEDLINE | ID: mdl-21182937

ABSTRACT

Multidrug resistance of bacterial pathogens is a major problem and there is a clear need for the development of new types of antibiotics. Here we investigated the antimicrobial activity of ruthenium(II) based DNA-intercalating complexes. These complexes were found to have no activity in vitro against the Gram-negative bacterium Escherichia coli, but the complexes were clearly active against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.


Subject(s)
Bacillus subtilis/drug effects , Intercalating Agents/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Ruthenium Compounds/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Caenorhabditis elegans/microbiology , Drug Resistance, Multiple, Bacterial/drug effects , Escherichia coli/drug effects , Intercalating Agents/chemical synthesis , Microbial Sensitivity Tests , Models, Animal , Ruthenium Compounds/chemical synthesis , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...